US Patent
US11476952 — Pharma-informatics system
Formulation · Assigned to Otsuka Pharmaceutical Co Ltd · Expires 2026-04-28 · 0y expired
Vulnerability score
53/100
Moderate — design-around opportunities exist
What this patent protects
This patent protects a power source apparatus that generates power and information encoded in a current flow within a conducting medium.
USPTO Abstract
An apparatus that includes a partial power source including a first material and a second material, the partial power source configured to generate, upon contact with a conducting medium, a potential difference between the first material and the second material to provide power to a control device, and generate, using the first material and the second material, a current flow within the conducting medium, the current flow including information encoded based on a variable conductance between the first material and the second material.
Drugs covered by this patent
- Abilify (aripiprazole) · Generic (originally Otsuka/BMS)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.